Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2015

Open Access 01-12-2015 | Letter to the Editor

High prevalence of hyposalivation in individuals with neurofibromatosis 1: a case–control study

Authors: Karin Soares Cunha, Rafaela Elvira Rozza-de-Menezes, Eloá Borges Luna, Lilian Machado de Sousa Almeida, Raquel Richelieu Lima de Andrade Pontes, Paula Nascimento Almeida, Letícia Vidaurre de Aguiar, Eliane Pedra Dias

Published in: Orphanet Journal of Rare Diseases | Issue 1/2015

Login to get access

Abstract

Background

Neurofibromatosis type 1 (NF1) is one of the most common genetic diseases in humans and has widely variable expressivity. Oral manifestations are common, but there are no studies that investigated functional alterations in salivary glands in NF1. Our aim was to evaluate the salivary flow rate in NF1 individuals, comparing to a control group, and to investigate the possible causes and some consequences of salivary gland alteration.

Methods

This is a case–control study that evaluated the salivary flow rate of NF1 individuals (n = 49) and compared to an age and sex-matched control group. We have also investigated the possible causes and consequences of hyposalivation in NF1 individuals through anamnesis, a specific questionnaire, physical examination, tongue coating evaluation and cytopathological exam to assess the prevalence of oral candidiasis.

Results

Hyposalivation at rest was present in 59% (29/49) of NF1 individuals in contrast to 22% (11/49) in the control group, being statistically significant (P <0.0001; Wilcoxon rank-sum test). The analysis of the adjusted residual showed that the prevalence of hyposalivation in NF1 individuals (46.9%) was 4-fold higher than in controls (10.2%). None of the possible causes of hyposalivation (medications, low liquid intake, caffeinated or stimulant drink use, mouth breathers, alcohol, smoke and plexiform neurofibroma close to or involving major salivary glands areas) had important impact on the salivary flow rate in NF1 individuals.

Conclusions

Hyposalivation may be a consequence of NF1, as occurs in other genetic diseases. More studies are necessary to understand if there is and what is the relationship between NF1 and hyposalivation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cunha KSG, Geller M. Advances in Neurofibromatosis Research. New York: Nova Science Publishers Inc; 2011. Cunha KSG, Geller M. Advances in Neurofibromatosis Research. New York: Nova Science Publishers Inc; 2011.
2.
go back to reference Shapiro SD, Abramovitch K, Van Dis ML, Skoczylas LJ, Langlais RP, Jorgenson RJ, et al. Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol. 1984;58:493–8.CrossRefPubMed Shapiro SD, Abramovitch K, Van Dis ML, Skoczylas LJ, Langlais RP, Jorgenson RJ, et al. Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol. 1984;58:493–8.CrossRefPubMed
3.
go back to reference Cunha KS, Barboza EP, Dias EP, Oliveira FM. Neurofibromatosis type I with periodontal manifestation. A case report and literature review. Br Dent J. 2004;196:457–60.CrossRefPubMed Cunha KS, Barboza EP, Dias EP, Oliveira FM. Neurofibromatosis type I with periodontal manifestation. A case report and literature review. Br Dent J. 2004;196:457–60.CrossRefPubMed
4.
go back to reference D’Ambrosio JA, Langlais RP, Young RS. Jaw and skull changes in neurofibromatosis. Oral Surg Oral Med Oral Pathol. 1988;66:391–6.CrossRefPubMed D’Ambrosio JA, Langlais RP, Young RS. Jaw and skull changes in neurofibromatosis. Oral Surg Oral Med Oral Pathol. 1988;66:391–6.CrossRefPubMed
5.
go back to reference Bardellini E, Amadori F, Flocchini P, Conti G, Piana G, Majorana A. Oral findings in 50 children with neurofibromatosis type 1. A case control study. Eur J Paediatr Dent Off J Eur Acad Paediatr Dent. 2011;12:256–60.CrossRef Bardellini E, Amadori F, Flocchini P, Conti G, Piana G, Majorana A. Oral findings in 50 children with neurofibromatosis type 1. A case control study. Eur J Paediatr Dent Off J Eur Acad Paediatr Dent. 2011;12:256–60.CrossRef
6.
go back to reference Javed F, Ramalingam S, Ahmed HB, Gupta B, Sundar C, Qadri T, et al. Oral manifestations in patients with neurofibromatosis type-1: a comprehensive literature review. Crit Rev Oncol Hematol. 2014;91:123–9.CrossRefPubMed Javed F, Ramalingam S, Ahmed HB, Gupta B, Sundar C, Qadri T, et al. Oral manifestations in patients with neurofibromatosis type-1: a comprehensive literature review. Crit Rev Oncol Hematol. 2014;91:123–9.CrossRefPubMed
7.
go back to reference Stumpf DA, Alksne JF, Annegers JF, Brown SS, Conneally PM, Housman D, et al. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575–8.CrossRef Stumpf DA, Alksne JF, Annegers JF, Brown SS, Conneally PM, Housman D, et al. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575–8.CrossRef
8.
go back to reference Mantilla Gómez S, Danser MM, Sipos PM, Rowshani B, van der Velden U, van der Weijden GA. Tongue coating and salivary bacterial counts in healthy/gingivitis subjects and periodontitis patients. J Clin Periodontol. 2001;28:970–8.CrossRefPubMed Mantilla Gómez S, Danser MM, Sipos PM, Rowshani B, van der Velden U, van der Weijden GA. Tongue coating and salivary bacterial counts in healthy/gingivitis subjects and periodontitis patients. J Clin Periodontol. 2001;28:970–8.CrossRefPubMed
9.
go back to reference Shimizu T, Ueda T, Sakurai K. New method for evaluation of tongue-coating status. J Oral Rehabil. 2007;34:442–7.CrossRefPubMed Shimizu T, Ueda T, Sakurai K. New method for evaluation of tongue-coating status. J Oral Rehabil. 2007;34:442–7.CrossRefPubMed
10.
go back to reference Picciani BLS, Silva-Junior GO, Michalski-Santos B, Avelleira JCR, Azulay DR, Pires FR, et al. Prevalence of oral manifestations in 203 patients with psoriasis. J Eur Acad Dermatol Venereol JEADV. 2011;25:1481–3.CrossRef Picciani BLS, Silva-Junior GO, Michalski-Santos B, Avelleira JCR, Azulay DR, Pires FR, et al. Prevalence of oral manifestations in 203 patients with psoriasis. J Eur Acad Dermatol Venereol JEADV. 2011;25:1481–3.CrossRef
11.
go back to reference Löfgren CD, Wickström C, Sonesson M, Lagunas PT, Christersson C. A systematic review of methods to diagnose oral dryness and salivary gland function. BMC Oral Health. 2012;12:29.CrossRefPubMedCentralPubMed Löfgren CD, Wickström C, Sonesson M, Lagunas PT, Christersson C. A systematic review of methods to diagnose oral dryness and salivary gland function. BMC Oral Health. 2012;12:29.CrossRefPubMedCentralPubMed
12.
go back to reference Van der Putten G-J, Brand HS, Schols JMGA, de Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clin Oral Investig. 2011;15:185–92.CrossRefPubMedCentralPubMed Van der Putten G-J, Brand HS, Schols JMGA, de Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clin Oral Investig. 2011;15:185–92.CrossRefPubMedCentralPubMed
13.
go back to reference Crema VO, Hamassaki DE, Santos MF. Small Rho GTPases are important for acinus formation in a human salivary gland cell line. Cell Tissue Res. 2006;325:493–500.CrossRefPubMed Crema VO, Hamassaki DE, Santos MF. Small Rho GTPases are important for acinus formation in a human salivary gland cell line. Cell Tissue Res. 2006;325:493–500.CrossRefPubMed
14.
go back to reference Xu N, Keung B, Myat MM. Rho GTPase controls invagination and cohesive migration of the Drosophila salivary gland through Crumbs and Rho-kinase. Dev Biol. 2008;321:88–100.CrossRefPubMed Xu N, Keung B, Myat MM. Rho GTPase controls invagination and cohesive migration of the Drosophila salivary gland through Crumbs and Rho-kinase. Dev Biol. 2008;321:88–100.CrossRefPubMed
15.
go back to reference Vallée B, Doudeau M, Godin F, Gombault A, Tchalikian A, de Tauzia M-L, et al. Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathways. PLoS One. 2012;7:e47283.CrossRefPubMedCentralPubMed Vallée B, Doudeau M, Godin F, Gombault A, Tchalikian A, de Tauzia M-L, et al. Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathways. PLoS One. 2012;7:e47283.CrossRefPubMedCentralPubMed
16.
go back to reference Ozawa T, Araki N, Yunoue S, Tokuo H, Feng L, Patrakitkomjorn S, et al. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. J Biol Chem. 2005;280:39524–33.CrossRefPubMed Ozawa T, Araki N, Yunoue S, Tokuo H, Feng L, Patrakitkomjorn S, et al. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. J Biol Chem. 2005;280:39524–33.CrossRefPubMed
17.
go back to reference Kimura N, Watanabe T, Fukase M, Wakita A, Noshiro T, Kimura I. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen’s disease. Mod Pathol Off J U S Can Acad Pathol Inc. 2002;15:183–8. Kimura N, Watanabe T, Fukase M, Wakita A, Noshiro T, Kimura I. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen’s disease. Mod Pathol Off J U S Can Acad Pathol Inc. 2002;15:183–8.
18.
go back to reference Foster PN, Stewart M, Lowe JS, Atkinson M. Achalasia like disorder of the oesophagus in von Recklinghausen’s neurofibromatosis. Gut. 1987;28:1522–6.CrossRefPubMedCentralPubMed Foster PN, Stewart M, Lowe JS, Atkinson M. Achalasia like disorder of the oesophagus in von Recklinghausen’s neurofibromatosis. Gut. 1987;28:1522–6.CrossRefPubMedCentralPubMed
19.
go back to reference Okazaki K, Kakita A, Tanaka H, Kimura K, Minagawa M, Morita T, et al. Widespread ischemic brain lesions caused by vasculopathy associated with neurofibromatosis type 1. Neuropathol Off J Jpn Soc Neuropathol. 2010;30:627–33.CrossRef Okazaki K, Kakita A, Tanaka H, Kimura K, Minagawa M, Morita T, et al. Widespread ischemic brain lesions caused by vasculopathy associated with neurofibromatosis type 1. Neuropathol Off J Jpn Soc Neuropathol. 2010;30:627–33.CrossRef
20.
go back to reference Danglot G, Régnier V, Fauvet D, Vassal G, Kujas M, Bernheim A. Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene. Hum Mol Genet. 1995;4:915–20.CrossRefPubMed Danglot G, Régnier V, Fauvet D, Vassal G, Kujas M, Bernheim A. Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene. Hum Mol Genet. 1995;4:915–20.CrossRefPubMed
Metadata
Title
High prevalence of hyposalivation in individuals with neurofibromatosis 1: a case–control study
Authors
Karin Soares Cunha
Rafaela Elvira Rozza-de-Menezes
Eloá Borges Luna
Lilian Machado de Sousa Almeida
Raquel Richelieu Lima de Andrade Pontes
Paula Nascimento Almeida
Letícia Vidaurre de Aguiar
Eliane Pedra Dias
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2015
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-015-0239-4

Other articles of this Issue 1/2015

Orphanet Journal of Rare Diseases 1/2015 Go to the issue